(SYBX) – Business Wire
-
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development
-
Scorpion Therapeutics Appoints Saurabh Saha, M.D., Ph.D. to its Board of Directors
-
Synlogic Outlines Upcoming Milestones for Clinical Programs and Unveils New Preclinical Pipeline Programs
-
Cerevance Appoints Clinical Development Veteran Dr. Aoife Brennan to Board of Directors
-
Synlogic Bridging Study Data with Solid Oral Formulation of SYNB1618, a Synthetic Biotic Approach to Treat Phenylketonuria, Demonstrate Improved Tolerability over Early Liquid Formulation and Guide to
-
Synlogic to Webcast Presentation at the Piper Jaffray 31st Annual Healthcare Conference
-
Synlogic Provides Program and Business Update and Reports Third Quarter 2019 Financial Results
-
Synlogic Announces Third Quarter 2019 Conference Call and Webcast
-
Synlogic to Present at the Chardan 3rd Annual Genetic Medicines Conference
-
Synlogic Announces Appointments of New CMO, Head of Regulatory Affairs, and CFO Departure
-
Synlogic Announces Appointments of New CMO, Head of Regulatory Affairs, and CFO Departure
-
Synlogic Presents Data from Phase 1/2a Study of SYNB1618 at the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism (SSIEM)
-
Synlogic Discontinues Development of SYNB1020 to Treat Hyperammonemia
-
Synlogic to Present at the 2019 Wedbush PacGrow Healthcare Conference
-
Synlogic Reports Second Quarter 2019 Financial Results and Provides Program Updates
-
Synlogic Announces Second Quarter 2019 Conference Call and Webcast
Back to SYBX Stock Lookup
